At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01099 SINOPHARM
Noon Closed 04-15 12:05:00
20.740
+0.360
+1.77%
High20.880Low20.380Vol1.08M
Open20.380D1 Closing20.380Amplitude2.45%
Mkt Cap64.73BTradable Cap27.83BTotal Shares3.12B
T/O22.26MT/O Rate0.08%Tradable Shares1.34B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Sinopharm Group Stock Falls 2.9% in Hong Kong
Dow Jones  ·  04-13 16:31
Sinopharm Group Stock Falls 2.9% in Hong Kong
Sinopharm schedules board meeting to review unaudited first-quarter results
Reuters  ·  04-10
Sinopharm schedules board meeting to review unaudited first-quarter results
Sinopharm Group Stock Slips 2.0% in Hong Kong
Dow Jones  ·  04-09
Sinopharm Group Stock Slips 2.0% in Hong Kong
Sinopharm Group Stock Advances 2.0% in Hong Kong
Dow Jones  ·  04-02
Sinopharm Group Stock Advances 2.0% in Hong Kong
Sinopharm Accord FY2025 Net Profit Jumps 76.80% to RMB1.14 Billion Despite Slight Revenue Dip
Bulletin Express  ·  04-01
Sinopharm Accord FY2025 Net Profit Jumps 76.80% to RMB1.14 Billion Despite Slight Revenue Dip
Sinopharm Accord net profit attributable to shareholders jumps 76.8% to RMB 1.136 billion
Reuters  ·  04-01
Sinopharm Accord net profit attributable to shareholders jumps 76.8% to RMB 1.136 billion
SINOPHARM Receives Additional Investment from Lazard Asset Management LLC Involving 2.1 Million Shares
Deep News  ·  03-30
SINOPHARM Receives Additional Investment from Lazard Asset Management LLC Involving 2.1 Million Shares
A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement
Simply Wall St.  ·  03-28
A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement
SINOPHARM Establishes New Subsidiary in Xiong'an
Deep News  ·  03-28
SINOPHARM Establishes New Subsidiary in Xiong'an
Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares
Stock News  ·  03-27
Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares
Sinopharm Group Stock Falls 3.6% in Hong Kong
Dow Jones  ·  03-24
Sinopharm Group Stock Falls 3.6% in Hong Kong
UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year
Stock News  ·  03-24
UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year
SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price
Stock News  ·  03-24
SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price
Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million
Reuters  ·  03-23
Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million
SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners
Stock News  ·  03-23
SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners
BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN
Reuters  ·  03-23
BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN
Sinopharm Group proposes final dividend of RMB 0.69 per share
Reuters  ·  03-23
Sinopharm Group proposes final dividend of RMB 0.69 per share
Sinopharm Group - FY Profit Attributable RMB7.16 Bln
THOMSON REUTERS  ·  03-23
Sinopharm Group - FY Profit Attributable RMB7.16 Bln
Sinopharm Group - Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed
THOMSON REUTERS  ·  03-23
Sinopharm Group - Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed
Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention
Simply Wall St.  ·  03-20
Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention

Introduction

Company Name.
SINOPHARM
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
Issue price:
--